Repaglinide + Voglibose is primarily used to manage blood sugar levels in adults with type 2 diabetes mellitus. This combination medication falls under the classes of meglitinides and alpha-glucosidase inhibitors.
In addition to its primary use, it effectively minimises blood sugar spikes after meals thereby reducing the risk of long-term complications associated with diabetes such as heart disease, kidney damage, nerve problems, and vision loss.
Upper respiratory tract infection
Diarrhoea
Flatulence or abdominal pain
Hypoglycaemia (low blood sugar)
Headache
Repaglinide + Voglibose is an anti-diabetic combination medicine.
Repaglinide is part of the meglitinide class. It works by stimulating the pancreas to release more insulin, a hormone that helps control blood sugar levels by enabling cells to take in and use glucose efficiently.
Voglibose is an alpha-glucosidase inhibitor. It slows down the digestion and absorption of carbohydrates in the intestines, thus reducing the amount of glucose that enters the bloodstream after a meal. This action helps prevent sudden spikes in blood sugar levels post-meal.
BDS, MDS
BMS, FMC, MD Resident
Repaglinide + Voglibose is available in the form of oral tablets.
This medication is administered orally, meaning it is swallowed usually with water.
Repaglinide + Voglibose is intended for adults only.
It is not recommended for use in children and teenagers under the age of 18 years.
Repaglinide + Voglibose is contraindicated in patients with type 1 diabetes.
This medication should not be used by individuals who have severe liver disease, diabetic ketoacidosis, or any kind of inflammatory bowel disease.
Patients with intestinal obstruction or colonic ulceration are also advised not to use this combination.
Repaglinide + Voglibose may interact with other antidiabetic medicines (such as insulin, metformin, etc.), calcium channel blockers (like nifedipine), and certain anti-seizure medications (like carbamazepine).
In case of an overdose, symptoms such as severe hypoglycaemia (low blood sugar) may occur. Patients should seek immediate medical help in case they experience symptoms like dizziness, confusion, excessive sweating, or palpitations.
If a dose of Repaglinide + Voglibose is missed, it should be taken as soon as the patient remembers. However, if it is close to the time for the next dose, then the missed dose should be skipped.
Most side effects are temporary and generally harmless and resolve when discontinuing this medicine. However, if you experience any severe side effects or worsening of any of the symptoms, please consult your doctor.
For managing hypoglycemia, always keep a source of sugar handy.
Drinking plenty of water may help with the side effects like diarrhoea and flatulence.
Repaglinide + Voglibose does not generally impair your ability to drive or operate machinery. However, if you do experience dizziness or weakness as a side effect of taking this medicine, then it would be advisable not to drive or operate machinery.
Pregnant and lactating women are advised to take Repaglinide + Voglibose only under the supervision of a doctor. Your doctor will decide whether this medication is safe for you based on your specific condition and circumstances.
Patients with moderate liver impairment, severe kidney disease, or G6PD deficiency should exercise caution while taking Repaglinide + Voglibose.
Also, individuals with a history of pancreatitis or gallbladder disease should inform their doctor before starting this medication.
Alongside taking Repaglinide + Voglibose, it is important to maintain a balanced diet which is low in simple sugars and high in fibre.
Regular monitoring of blood sugar levels is recommended to assess the effectiveness of the treatment.
Moderate physical activity on a regular basis is beneficial in managing type 2 diabetes.
Regular medical check-ups including eye and foot examinations are also advised for patients with diabetes.
Frequently asked questions
This medicine should be taken 15-30 minutes before each meal. If you skip a meal, you should also skip the dose of Repaglinide + Voglibose to avoid low blood sugar levels (hypoglycemia). Consult your doctor for best advice.
Weight gain is not listed as a common side effect of Repaglinide + Voglibose. However, individual responses to medication can vary. If you are concerned about weight changes while using this medicine, consult your doctor.
While some natural remedies may help support blood sugar control, they cannot replace conventional diabetes medication like Repaglinide + Voglibose. It is essential to discuss any alternative treatments with your doctor before starting them.
No, Repaglinide + Voglibose is not a steroid. It is a combination medicine used to manage type 2 diabetes.
Repaglinide + Voglibose might have an indirect impact on hormones as it influences the regulation of insulin, a hormone produced by the pancreas.
No, Repaglinide + Voglibose is not known to cause addiction or dependency.
The duration of effect can vary among individuals and depends on several factors including the dosage and the individual's body response. It is best to follow the dosing schedule as prescribed by your doctor.
Subscribe
Claim your complimentary health and fitness tips subscription and stay updated on our newest promotions.
Download Truemeds
Manage your health with ease Download Truemeds today!Get easy access to medicine refills, health information, and more. With our app, you'll never have to wait in line again. Download now and start taking control of your health.
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v3.4.14
Our Payment Partners